conducted within
one country (86.1%), as phase Ⅳ (34.1%) interventional study (82.7%), randomized (52
Introduction Neurofibromatosis type 1 (NF1) is
one of the most common hereditary tumor syndromes
Motloch, LJ;,
Jirak, P;,
Gareeva, D;,
Davtyan, P;,
Gumerov, R;,
Lakman, I;,
Tataurov, A;,
Zulkarneev, R;,
Kabirov, I;,
Cai, BZ;,
Valeev, B;,
Pavlov, V;,
Kopp, K;,
Hoppe, UC;,
Lichtenauer, M;,
Fiedler, L;,
Pistulli, R;,
Zagidullin, N (2022) .081, CI 95% 1.035;1.129, p = 0.017), but not ST2 or hs-TnI. In contrast, during
one-year FU post hospital
Wu, JN,
Al-Zahrani, A,
Beylerli, O,
Sufianov, R,
Talybov, R,
Meshcheryakova, S,
Sufianova, G,
Gareev, I,
Sufianov, A (2022) including three downexpressed miRNAs and
one overexpressed (miR-181a, miR-181b and miR-410; miR-155) in high
Xu, Dongxiao,
Zheng, Bingjie,
Wu, Qiaowei,
Yao, Jinbiao,
Ilyasova, Tatiana,
Beilerli, Aferinc,
Shi, Huaizhang (2022) .2%) patients, cerebral infarction in 3 (4.5%) patients (including
one case accompanied by wound infection